Need professional-grade analysis? Visit stockanalysis.com
$6.25B
N/A
N/A
N/A
Sumitomo Pharma Co. Ltd (SMDPY) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $11.75.
Over the past year, SMDPY has traded between a low of $4.78 and a high of $24.40. The stock has gained 145.8% over this period. It is currently 51.8% below its 52-week high.
Sumitomo Pharma Co. Ltd has a market capitalization of $6.25B.
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Side-by-side comparison against top Healthcare peers.